Financhill
Back

Design Therapeutics Quote, Financials, Valuation and Earnings

Design Therapeutics Price Quote

$3.63
-0.09 (-2.42%)
(Updated: May 6, 2024 at 1:40 PM ET)

Design Therapeutics Key Stats

Sell
39
Design Therapeutics (DSGN) is a Sell

Day range:
$3.65 - $3.83
52-week range:
$1.94 - $8.47
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.76%

Volume:
174K
Avg. volume:
315.7K
1-year change:
-48.26%
Market cap:
$210.2M
Revenue:
$0
EPS:
$-1.2

How Much Does Design Therapeutics Make?

Data Unavailable

Is Design Therapeutics Growing As A Company?

Data Unavailable

Design Therapeutics Stock Price Performance

What Is Design Therapeutics 52-Week High & Low?

Design Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Design Therapeutics?

Is Design Therapeutics Cash Flow Positive?

  • What Is DSGN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$58.6M
  • What Is Design Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $724K
  • What Is Design Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $52.5M

Design Therapeutics Return On Invested Capital

Data Unavailable

Design Therapeutics Earnings Date & Stock Price

Design Therapeutics Competitors

Design Therapeutics Dividend Yield

Data Unavailable

Design Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 33.69%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 4.67
Upside from Last Price: 25.45%

Major Shareholders

  • How many DSGN shares are owned by institutional investors?
    36.3M DSGN shares are owned by institutional investors
  • How many DSGN shares are owned by insiders?
    1.2M DSGN shares are owned by insiders